Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Tri-Point seeks FDA approval for TraumaSeal

Jan. 8, 1997

Regranex update

Jan. 7, 1997

Oral contraceptive cleared by FDA as acne treatment

Jan. 7, 1997

Sugen files IND for antipsoriatic agent

Jan. 7, 1997

Mentax approved for two new indications by FDA

Jan. 7, 1997

FDA clears Rogaine generic

Jan. 3, 1997

Another new application for botulinum toxin reported in the literature

Jan. 3, 1997

First Rx for oral ulcers cleared by FDA

Dec. 23, 1996

1997 launch anticipated for scar management device from Life Medical Sciences

Dec. 20, 1996

Connective Therapeutics reports progress on interferon gamma

Dec. 20, 1996

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...